Back to search
FDAFDA · Food and drugs·Recall number D-0160-2020

Lyophilized Human Chorionic Gonadotropin 5,500 USP Units For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910

Published November 6, 2019 · Recall initiated: October 10, 2019

Summary

FDA records drug Class II recall D-0160-2020, published November 6, 2019 and initiated October 10, 2019. Recalling firm: Innoveix Pharmaceuticals Inc; Status: Terminated; Reported quantity: 290 vials; Lot: Lots: INX 50 Exp. 5/1/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Innoveix Pharmaceuticals Inc
Distributor
Nationwide within the United States
Lot
Lots: INX 50 Exp. 5/1/20
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lyophilized Human Chorionic Gonadotropin 5,500 USP Units For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910 recalled?

Yes. FDA published recall D-0160-2020 on November 6, 2019. Reported hazard: Lack of Sterility Assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release